In contrast to non-small cell lung cancer and adenocarcinoma harboring activating nucleotide mutations within the EGFR kinase domain, GBM overly activates EGFR by the increasing copy number and the substituted mutations occur in the extracellular domain (39) (Figure 4). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.